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Background In the pre-diagnostic phase of Parkinson’s disease (PD), a range of 
motor and non-motor symptoms can occur. However, there is considerable variability 
in their onset and currently little information exists on the pattern of progression of 
clinical features before diagnosis.  
Methods We analysed data from a survey amongst patients with PD from 11 
European countries by the European Parkinson’s Disease Association. They 
completed questions on first occurrence of 21 pre-diagnostic features. A principal 
component analysis (PCA) with varimax rotation was performed to determine the co-
occurrence of these features. 
Findings 1,467 patients were included. Changes in movement were the most 
commonly reported features up to 4 years before diagnosis. However, at five or more 
years before diagnosis loss of sense of smell, sleep problems, fatigue and other non-
motor features had been experienced most frequently. PCA of pre-diagnostic features’ 
duration revealed three factors with eigenvalues over Kaiser’s criterion of 1: a) a 
neuropsychiatric factor comprised of anxiety, depression, apathy, stress, and sleep 
problems; b) an axial factor defined by difficulty eating and/or swallowing problems, 
freezing, and falls/balance problems; and c) a motor factor with additional non-motor 
features. Bladder/bowel problems and tremor had low factor loadings on all 
components. However, in those with disease duration less than 5 years the autonomic 
features were associated with the axial factor and tremor loaded on both the motor 
and psychiatric symptom factors. 
Interpretation The identified symptom complexes in the pre-diagnostic stage of PD 




Non-motor and subtle motor features of Parkinson’s disease (PD) can begin several 
years before a diagnosis of PD is made (1). However, there is considerable inter-
individual variability and whilst some patients experience predominantly tremor or 
motor problems before diagnosis, others have olfactory loss, autonomic, cognitive, 
sleep-related, or psychiatric features, and these initial symptoms may reflect early 
involvement of different pathological areas (2) (3) (4). In established PD, subgroups 
with different clinical phenotypes, reflecting underlying sequential biological 
pathways and clinical progression rates, have been proposed (3). However, there is 
little information on the pattern and simultaneous occurrence of different symptoms 
in the pre-diagnostic phase. In an attempt to address this gap in knowledge we 
analysed data from a large number of patients with PD reporting the duration of their 




Data were extracted from a survey conducted by the European Parkinson’s Disease 
Association (EPDA) in 11 European countries (5). This included questions on first 
symptoms and their duration before diagnosis. Participants were recruited through 
PD associations in Germany, France, Netherlands, Sweden, UK, Slovenia, Spain, 
Italy, Hungary, Ireland, and Denmark.  The survey was completed online in all 
countries apart from patients in Slovenia, where hard copies were distributed 
because of restricted access to the internet. Data were collected from 1st November 




The self-administered survey included questions on demographics, country, disease 
duration and questions about the presence of symptoms and their duration before 
diagnosis. These included loss of smell or taste, sleep problems, low blood pressure 
or dizziness, bladder and bowel problems, skin and/or sweating problems, pain, 
thinking or memory problems, anxiety, apathy, depression, feeling of stress, 
slowness of movement, changes in movements (including arm swing), falls (balance 
problems), freezing, communication problems (including speech and handwriting), 
difficulty eating and/or swallowing, muscle cramps, rigidity (stiffness), fatigue and 
tremor. For each symptom, duration of symptoms before diagnosis was reported as: 
less than one year, 1 to 2 years, 3 to 4 years, or 5 years or more before diagnosis, or 
symptom not preceding diagnosis.  
 
Statistical analysis 
Descriptive data are presented as percentages and medians for each symptom. A 
factor analysis of the 21 pre-diagnostic symptoms using the principal component 
method with varimax rotation was performed to establish the underlying dimensions 
of co- occurrence, which might reflect underlying pathological substrates. Factor 
loadings were determined using a cut-off for at least fair loading (<0.45) (6, 7). 
Factors with eigenvalues over Kaiser’s criterion of 1 were retained and the 
percentage of variance of the data explained calculated (Figure 1 supplementary 
material). As recall bias may affect the results particularly in those with disease onset 
more than 5 years ago, we also undertook at sensitivity analysis excluding those with 
a disease duration of 5 years or more. 
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1775 participants completed the survey. Data for the analysis were available for 
1467 patients excluding those that did not fully complete the scale of 21 symptoms 
(n=130) or gave impossible or contradictory information on age and disease duration 
(n=178). Table 1 below shows the demographic profile of participants and table 1 
supplementary material that of participants with <5 years duration only. 
 
Symptoms experienced before diagnosis  
The number of patients that had experienced each symptom before diagnosis is 
presented in figure 1, and their occurrence by time before diagnosis in table 2. The 
most commonly reported symptoms before diagnosis overall were changes in gait 
(80.2 %), slowness of movement (60.5 %), tremor (57.3 %), stiffness/rigidity (54.7 %), 
fatigue (53.9 %) and communication problems (including speech/handwriting), (53.5 
%). At more than 5 years before diagnosis, on the other hand, the most frequently 
experienced symptom was loss of smell (15.1%), followed by sleep problems (11.5%), 
fatigue (11.3%), stress (11%) and bladder/bowel problems (10.4%). Tremor and 
slowness of movement most commonly occurred in the 2 years before diagnosis. In 
the subgroup of those with <5 years duration results were similar (suppl table 2). 
 
Factor Analysis of pre-diagnostic symptoms 
Exploratory factor analysis revealed three factors with eigenvalues over Kaiser’s 
criterion of 1 indicating co-occurrence of symptoms: A neuropsychiatric symptom 
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complex of anxiety, depression, apathy, stress, and sleep problems; an axial motor 
symptom complex including freezing, falls/balance problems, difficulty eating and/or 
swallowing, slowness of movement and communication (speech/handwriting) 
problems; and a motor factor that also included sensory, cognitive and autonomic 
nonmotor features, encompassing slowness of movement, fatigue, rigidity/stiffness, 
muscle cramps, pain, changes in movement (including arm swing), 
speech/handwriting problems, loss of smell or taste, thinking or memory problems, 
stress, sleep disturbances, skin and/or sweating problems, and low blood pressure or 
dizziness. Tremor and bladder/bowel problems had low factor loading on all 
components. However, in the sensitivity analysis restricted to those with a diagnosis 
within 5 years, bladder and bowel problems and low blood pressure./dizziness also 
loaded on the axial factor, and tremor loaded on both motor and psychiatric symptom 
factors. The motor factor split into two factors characterised by slowness of movement 
and fatigue: one including rigidity, muscle cramps, pain, sleeping problems and stress, 
and another including changes in movement (including arm swing), 
speech/handwriting problems, tremor, thinking or memory problems and loss of sense 
of smell or taste. Factor loadings are shown in table 3 (whole cohort) and 4 
(participants within 5 years of diagnosis).  
 
Discussion 
The symptoms most frequently noted by patients in the pre-diagnostic phase of PD, 
when reported retrospectively in this large cohort of patients with PD, were related to 
disturbances of motor function, reflecting the classical features leading to a diagnosis 
of PD. Tremor and slowness most commonly occurred relatively shortly before 
diagnosis. However, the feature most frequently reported more than 5 years before 
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diagnosis was loss of smell followed by other pre-diagnostic features, including sleep 
disturbances, fatigue, stress, and bladder and bowel problems, before slowness and 
changes in movement were noted. Many of these, such as fatigue, bladder and 
bowel problems, and sleep disturbances, are frequently reported in non-PD patients, 
but are also clinical features that can predate motor features in the general 
population (1). Whilst our study design does not allow definite attribution of these 
complaints to PD, their occurrence in the five years before PD diagnosis is 
consistent with previous reports (1). Loss of sense of smell in the absence of 
causative local pathology or medication is relatively specific as a preclinical feature 
of neurodegenerative disease, but other neurodegenerative diseases can also be 
associated with this feature (8).  
There were at least three distinct initial symptom complexes in this population: 
Neuropsychiatric features (anxiety, depression, apathy, sleep disturbances and 
stress) were experienced together, consistent with their known overlapping clinical 
phenomenology and pathophysiology. Similarly, axial features (falls/balance 
problems, difficulty eating and/or swallowing, communication (speech/handwriting) 
problems, and slowness of movement) which may be seen together in more 
aggressive subtypes of parkinsonism occurred together, suggesting a shared 
underlying pathology, possibly within midbrain neurodegeneration (9). This 
explanation is also suggested by the finding that in the analysis restricted to those 
with a shorter time since diagnosis the autonomic features of low blood pressure or 
dizziness and bladder and bowel problems loaded onto the same factor as axial 
features. The largest factor included all other features related to motor impairment as 
well as cognitive, sensory and autonomic features. However, the sensitivity analysis 
suggested that motor features related to rigidity and pain, as well as sleep 
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disturbances occur in a different pattern than those related to other motor features 
including handwriting, reduced arm swing and tremor as well as loss of smell or 
taste. There was some overlap between the factors. Experiences of sleep 
disturbances and of stress occurred together with both the neuropsychiatric features 
and with the features related to motor impairment. This is likely to reflect the 
multifactorial nature of these features. Similarly, reports of slowness and of the 
combined question on communication difficulties due to speech and handwriting 
problems loaded on several factors, reflecting the broadness of the questions. 
Thinking and memory problems loaded comparably on all motor factors indicating 
indicating the lack of specificity of this question. Report of tremor did not load highly 
on any of the factors in the overall cohort, suggesting that it appears to develop at a 
different time than other pre-diagnostic features of PD. However, in the analysis 
restricted to those with a shorter disease duration, who are less likely to be affected 
by recall bias, tremor occurrence was associated with both apendicular motor 
features and psychiatric features, including anxiety, which may enhance an existing 
subtle tremor.  
Whilst we are not aware of other studies exploring the temporal relationship between 
occurrence of prediagnostic features of PD, our results of retrospective reports of 
these features in patients with PD are comparable to others, with a range of pre-
diagnostic features reportedly having occurred several years before diagnosis, 
without differences between different motor subtypes (Pont-Sunyer, Hotter et al. 
2015). In addition to our own data based on primary care presentations before 
diagnosis of PD (1), others reported that pre-diagnostic features were experienced 
by patients with PD 10-15 years before diagnosis (10), and reported retrospectively 
that hyposmia, constipation, sleep disturbances, depression and anxiety had been 
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present many years before motor features (11-15). These features have been used 
successfully to help predict occurrence of PD as components of the MDS research 
criteria for prodromal PD (Mahlknecht, Gasperi et al. 2018; Fereshtehnejad, 
Montplaisir et al. 2017, Pilotto, Heinzel et al. 2017, Mahlknecht, Gasperi et al. 2018) 
Limitations 
The main limitation of this study is that it is a study of retrospectively reported initial 
symptoms in patients with a range of different disease duration, which may be 
subject to recall bias and individual experiences. In addition, there was no control 
group and it is likely that not all of the symptoms were due to PD. However, all 
features surveyed have been previously reported to be increased in patients with PD 
in the prediagnostic phase(1) and were attributed to PD by patients who were later 
diagnosed with PD. To our knowledge this is the first analysis of the temporal co-
occurrence of prediagnostic motor and non-motor features of PD. The large sample 
size enabled robust conclusions on when prediagnostic features of PD are first 
experienced by patients with a later diagnosis of PD.  
The results of this study also suggest that there are distinct combinations of clinical 
features in the prediagnostic phase of PD, which occur in a similar timeframe before 
diagnosis. These may reflect initial involvement of different underlying pathological 
areas and pathophysiological progression patterns. Assessing occurrence of these 
subgroups of prediagnostic features of PD may be helpful to differentially assess 
































Demographic Profile Disease Duration 
 M (SD) Mdn 
(IQR) 













    Disease duration  7.79 (5.67) 6 (7) 
Gender n (%)     
Males 791 53.9 %     
Females 676 46.1 %     
    Length of diagnosis n (%) 
Area n (%)     
Rural 
 
278 19 %   Less than 1 year 143 9.7 % 
Town 530 36.2 %   At least 1 year but 
less than 2 years 
134 9.1 % 
City 658 44.9 %  At least 2 years but 
less than 3 years 
172 11.7 % 
    At least 3 years but 
less than 5 years 
252 17.2 % 
Employment n (%)  At least 5 years but 
less than 10 years 
436 29.7 % 
Employed  292 19.9 %  More than 10 years 329 22.4 % 
Unemployed  1175 80.1 %     





Table 2. Number (%) of patients that experienced each symptom before diagnosis by time before onset.  
Symptom 5 years or 
more (%) 
3-4 years (%) 1 to 2 years 
(%) 
Less than 1 
year (%) 
Total n without 
symptom (%) 
Loss of smell or taste  
 
222 (15.1) 134 (9.1) 134 (9.1) 161 (11) 815 (55.6) 
Sleep problems 
 
168 (11.5) 122 (8.3) 182 (12.4) 156 (10.6) 838 (57.1) 
Fatigue  166 (11.3) 157 (10.7) 250 (17) 218 (14.9) 676 (46.1) 
Stress  
 
162 (11) 137 (9.3) 188 (12.8) 144 (9.8) 834 (56.9) 
Bladder and bowel 
problems  
153 (10.4) 103 (7) 128 (8.7) 85 (5.8) 997 (68) 
Changes in movement 138 (9.4) 211 (14.4) 492 (33.5) 336 (22.9) 290 (19.8) 
Pain  135 (9.2) 115 (7.8) 182 (12.4) 160 (10.9) 874 (59.6) 
Rigidity/stiffness  128 (8.7) 144 (9.8) 267 (18.2) 264 (18) 662 (45.1) 
Low blood pressure or 
dizziness  
115 (7.8) 84 (5.7) 120 (8.2) 121 (8.2) 1026 (69.9) 
Depression  108 (7.4) 83 (5.7) 119 (8.1) 98 (6.7) 1059 (72.2) 
Muscle cramps 
 
105 (7.2) 118 (8) 201 (13.7) 200 (13.6) 841 (57.3) 
Skin and/or sweating 
problems 
105 (7.2) 81 (5.5) 113 (7.7) 97 (6.6) 1069 (72.9) 
Tremor  105 (7.2) 107 (7.3) 262 (17.9) 365 (24.9) 626 (42.7) 
Slowness of movement 
  
101 (6.9) 146 (10) 334 (22.8) 305 (20.8) 580 (39.5) 
Anxiety  90 (6.1) 65 (4.4) 83 (5.7) 121 (8.2) 1096 (74.7) 
Communication (incl. 
speech or handwriting) 
89 (6.1) 133 (9.1) 270 (18.4) 292 (19.9) 682 (46.5) 
Thinking or memory  
problems  
73 (5) 96 (6.5) 169 (11.5) 193 (13.2) 935 (63.7) 
Falls/balance problems 64 (4.4) 81 (5.5) 142 (9.7) 170 (11.6) 1009 (68.8) 
Apathy  
 
46 (3.1) 44 (3) 98 (6.7) 84 (5.7) 1195 (81.5) 


















Table 3. Factor loadings for each clinical feature 
 Component 
Symptom 1 2 3 
Rigidity/stiffness  .686 .106 .321 
Slowness of movement  .634 .096 .466 
Muscle cramps .626 .273 .123 
Fatigue .617 .368 .229 
Changes in movements, incl. arm swing .590 .046 .326 
Stress .583 .539 .010 
Pain .578 .308 .157 
Loss of smell or taste .546 .031 .111 
Thinking or memory problems .535 .232 .372 
Communication (incl. speech or 
handwriting) 
.507 .095 .490 
Sleep problems .499 .475 .211 
Skin and/or sweating problems .473 .410 .203 
Low blood pressure or dizziness  .462 .244 .284 
Tremor/shaking .313 .305 .052 
Anxiety .141 .804 .170 
Depression .214 .775 .173 
Apathy .004 .692 .370 
Bladder and bowel problems .308 .365 .339 
Difficulty eating and/or swallowing .132 .278 .707 
Freezing .248 .195 .700 
Falls (balance problems) .330 .191 .657 
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Table 4. Factor loadings for each clinical feature in those within 5 years of diagnosis 
 Component 
Symptom 1 2 3 4 
Rigidity/stiffness .612 .027 .244 .441 
Slowness of movement .459 .025 .351 .553 
Muscle cramps .712 .143 .160 .152 
Fatigue .491 .312 .219 .467 
Changes in movements, incl. arm swing .328 .106 .228 .558 
Stress .490 .521 .082 .328 
Pain .708 .181 .219 .066 
Loss of smell or taste -.028 .117 .188 .653 
Thinking or memory problems .305 .229 .352 .463 
Communication (incl. speech or handwriting) .280 .135 .294 .553 
Sleep Problems .548 .470 .257 .092 
Skin and/or sweating problems .513 .343 .242 .127 
Low blood pressure or dizziness .314 .081 .525 .205 
Tremor/shaking .042 .478 -.174 .496 
Anxiety .211 .792 .181 .121 
Depression .244 .752 .191 .163 
Apathy .054 .685 .416 .084 
Bladder and bowel problems .234 .313 .550 .047 
Difficulty eating and/or swallowing .017 .252 .616 .248 
Freezing .230 .103 .631 .192 
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